Vontobel Financial Products GmbH Share Price

Certificat

DE000VD2W696

Real-time Bid/Ask 02:48:05 27/06/2024 pm IST
95.38 EUR / 95.83 EUR -1.31% Intraday chart for Vontobel Financial Products GmbH
Current month-1.51%
1 month-3.30%
Date Price Change
27/24/27 95.43 -1.49%
26/24/26 96.87 -0.74%
25/24/25 97.59 +1.29%
24/24/24 96.35 -0.05%
21/24/21 96.4 +0.97%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 01:21 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD2W69
ISINDE000VD2W696
Date issued 27/03/2024
Strike 34.15 $
Maturity 27/03/2025 (274 Days)
Parity 0.03 : 1
Emission price 100
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 102.4
Lowest since issue 92.78
Spread 4.5
Spread %0.47%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus